Cognitive effects of chemotherapy-induced menopause in breast cancer

Clinical Neuropsychologist

Volumn 25, Issue 8, 2011, Pages 1295-1313

  Vearncombe, Katharine J ^a,b   Rolfe, Margaret ^c,d   Andrew, Brooke ^a,b   Pachana, Nancy A ^a   Wright, Margaret ^e   Beadle, Geoffrey ^e  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b WESLEY HOSPITAL   (Australia)

^c SOUTHERN CROSS UNIVERSITY   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Chemotherapy; Induced menopause; Memory; Neurotoxicity

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; LEARNING; MEMORY; MENOPAUSE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; SELF REPORT; STATISTICAL MODEL;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; MEMORY; MENOPAUSE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SELF REPORT; VERBAL LEARNING;

EID: 84857299087     PISSN: 13854046     EISSN: 17444144     Source Type: Journal    
DOI: 10.1080/13854046.2011.631586     Document Type: Article

References (50)

1. Ahles, T. A., & Saykin, A. J. (2001). Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Investigation, 19(8), 812-820. (Pubitemid 33151212)
2. Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews, 7, 192-201.
3. Asthana, S. (2003). Estrogen and cognition: The story so far. Journal of Gerontology: Medical Sciences, 58A, 322-323. (Pubitemid 36397049)
4. Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., et al. (2006). Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology, 15, 422-430. doi: 10.1002/pon.964. (Pubitemid 43826855)
5. Bender, C. M., Sereika, S. M., Brufsky, A. M., Ryan, C. M., Vogel, V. G., Rastoqi, P., et al. (2007). Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause, 14, 995-998. (Pubitemid 350098658)
6. Bickel, R. (2006). Multilevel analysis for applied research: It's just regression! New York: The Guilford Press.
7. Brady, M. J., Cella, D. F., Bonomi, A. E., Tulsky, D. S., Lloyd, S. R., Deasy, S., et al. (1997). Reliability and validity of the Functional Assessment of Cancer - Breast quality-of-life instrument. Journal of Clinical Oncology, 15(3), 974-986. (Pubitemid 27106280)
8. Brezden, C. B., Phillips, K. A., Abdolell, M., Bunston, T., & Tannock, I. F. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 18, 2695-2701. (Pubitemid 30463551)
9. Del Mastro, L., Venturini, M., Sertoli, M. R., & Rosso, R. (1997). Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: Prognostic role and clinical implications. Breast Cancer Research and Treatment, 43, 183-190. (Pubitemid 27165879)
10. Delis, D. C., Kaplan, E., & Kramer, J. H. (2001). D-KEFS: Delis-Kaplan Executive Function System: Examiners manual. San Antonio, TX: The Psychological Corporation, Harcourt Assessment.
11. Donovan, K., Small, B. J., Andrykowski, M. A., Schmitt, F. A., Munster, P., & Jacobsen, P. B. (2005). Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early stage breast carcinoma. Cancer, 104(11), 2499-2507. doi: 10.1002/cncr.21482. (Pubitemid 41691574)
12. Downie, F. P., Mar Fan, H. G., Houede-Tchen, N., Yi, Q., & Tannock, I. F. (2006). Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: Evaluation with patient interview after formal assessment. Psycho-Oncology, 15, 921-930. doi: 10.1002/pon.1035. (Pubitemid 44612891)
13. Geffen, G., & Geffen, L. (2000). Auditory verbal learning test: Australian manual: Computerized scoring program and population norms. Melbourne: ACER Press.
14. Golden, C., & Freshwater, S. (2002). Stroop Color and Word Test: Revised examiners manual. Wood Dale, IL: Stroelting.
15. Hermelink, K., Henschel, V., Untch, M., Bauerfeind, I., Lux, M. P., & Munzel, K. (2008). Short term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients. Results of a multicenter, prospective, longitudinal study. Cancer, 113(9), 2431-2439. doi: 10.1002/cncr.23853.
16. Hermelink, K., Untuch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., et al. (2007). Cognitive function during neoadjuvant chemotherapy for breast cancer. Results of a prospective, multicenter, longitudinal study. Cancer, 109, 1905-1913. doi: 10.1002/cncr.22610. (Pubitemid 46668557)
17. Hurria, A., Somlo, G., & Ahles, T. (2007). Renaming "chemobrain". Cancer Investigations, 25, 373-377. doi: 10.1080/0735790070156672.
18. Jenkins, V., Shilling, V., Deutsch, D., Bloomfield, D., Morris, R., Allan, S., et al. (2006). A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. British Journal of Cancer, 94, 828-834. doi: 10.1038/sj.bjc.6603029.
19. Kok, H., Kuh, D., Cooper, R., van der Shouw, Y. T., Grobbee, D. E., Wadsworth, M. E., et al. (2006). Cognitive function across the life course and the menopausal transition in a British birth cohort. Menopause, 13, 19-27.
20. Lezak, M. D. (1995). Neuropsychological assessment, 3rd edition. New York: Oxford University Press.
21. Mar Fan, H. G., Houede-Tchen, N., Yi, Q., Chemerynsky, I., Downie, F., Sabate, K., et al. (2005). Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. Journal of Clinical Oncology, 23, 8025-8032. doi: 10.1200/JCO.2005.01.6550. (Pubitemid 46657404)
22. Mehlsen, M., Pedersen, A. D., Jensen, A. B., & Zachariae, R. (2009). No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psycho-Oncology, 18(3), 248-257. doi: 10.1002/pon.1398.
23. Nappi, R. E., Sinforiani, E., Mauri, M., Bono, G., Polatti, F., & Nappi, G. (1999). Memory functioning at menopause: impact of age in ovariectomized women. Gynecologic and Obstetric Investigation, 47, 29-36. (Pubitemid 29026892)
24. Nelson, H. E., & Willison, J. (1991). National Adult Reading Test (NART) manual. New Tork: NFER-NELSON.
25. Phillips, S. M., & Sherwin, B. B. (1992). Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology, 17(5), 485-495. (Pubitemid 23015018)
26. Polo-Kantola, P., Portin, R., Polo, O., Helenius, H., Iriala, K., & Errkola, R. (1998). The effect of short-term estrogen replacement therapy on cognition: A randomized, doubleblind, cross-over trial in post-menopausal women. Obstetrics and Gynaecology, 91, 459-466. (Pubitemid 28119853)
27. Poniatowski, B., Grimm, P., & Cohen, G. (2001). Chemotherapy-induced menopause: A literature review. Cancer Investigation, 19(6), 641-648. (Pubitemid 32675218)
28. Rice, M. M., Graves, A. B., McCurry, S. M., Gibbons, L. E., Bowen, J. D., McCormick, W. C., et al. (2000). Post-menopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The KAME project. Archives of Internal Medicine, 160, 1641-1649. (Pubitemid 30367903)
29. Roberts, J. K. (2004). An introductory primer on multilevel and hierarchical linear modelling. Learning Disabilities: A Contemporary Journal, 2(1), 30-38.
30. Roberts, J. K., & Monaco, J. P. (April, 2006). Effect size measures for the two-level linear multilevel model. Presented at the American Education Research Association, San Francisco, USA.
31. Robertson, I. H., Ward, T., Ridgeway, V., & Nimmo-Smith, I. (1994). The Test of Everyday Attention: Manual. Bury St Edmunds, UK: Thames Valley Test Company.
32. Schagen, S. B., Muller, M. J., Boogerd, W., Mellenbergh, G. J., & van Dam, F. S. A. M. (2006). Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. Journal of the National Cancer Institute, 98, 1742-1745. doi: 10.1093/jnci/djj470. (Pubitemid 44942713)
33. Schagen, S. B., Muller, M. J., Boogerd, W., Rosenbrand, R. M., van Rhijn, D., Rodenhuis, S., et al. (2002). Late effects of adjuvant chemotherapy on cognitive function: A follow-up study in breast cancer patients. Annals of Oncology, 13, 1387-1397. doi: 10.1093/annonc/mdf241.
34. Schagen, S. B., van Dam, F. S. A. M., Muller, M. J., Boorgerd, W., Lindeboom, J., & Bruning, P. F. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer, 85(3), 640-650. (Pubitemid 29075285)
35. Sherwin, B. B. (1988). Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology, 13(4), 345-357.
36. Sherwin, B. B. (2006). The critical period hypothesis: Can it explain discrepancies in the estrogen-cognition literature? Journal of Neuroendocrinology, 19, 77-81. (Pubitemid 46043829)
37. Smith, A. (1982). Symbol Digit Modalities Test: Manual revised. Los Angeles: Western Psychological Services.
38. Strauss, E., Sherman, E. M. S., & Spreen, O. (2006). A compendium of neuropsychological tests: Administration, norms and commentary. New York: Oxford University Press.
39. Tager, F. A., McKinley, P. S., Schnabel, F. R., El-Tamer, M., Cheung, Y. K., Fang, Y., et al. (2010). The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Research and Treatment, 123(1), 25-34.
40. Tchen, N., Juffs, H. G., Downie, F. P., Yi, Q., Hu, H., Chemerynsky, I., et al. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, 21(22), 4175-4183. doi: 10.1200/JCO.2003.01.119. (Pubitemid 46606186)
41. The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group (2002). Anastrozole alone or in combination with Tamoxifen versus Tamoxifen alone for adjuvant treatment of post-menopausal women with early breast cancer: First results of the ATAC randomised trial. Lancet, 359, 2131-2139.
42. Tiffin, J. (1968). Purdue Pegboard: Examiner manual. Chicago: Science Research Associates.
43. van Dam, F. S. A. M., Schagen, S., Muller, M. J., Boogerd, W., Wall, E., Fortuym, D., et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High dose versus standard-dose chemotherapy. Journal of the National Cancer Institute, 90, 210-218. (Pubitemid 28114539)
44. Vardy, J., & Tannock, I. (2007). Cognitive function after chemotherapy in adults with solid tumours. Critical Reviews in Oncology/Hematology, 63, 183-202. doi: 10.1016/j.critrevonc.2007.06.001. (Pubitemid 47126866)
45. Verghese, J., Kuslansky, G., Katz, M. J., Sliwinski, M., Crystal, H. A., Buschke, H., & Lipton, R. B. (2000). Cognitive performance in surgically menopausal women on estrogen. Neurology, 55, 872-874.
46. Wechsler, D. (1997a). Wechsler Memory Scale: Administration and scoring manual, 3rd ed. San Antonio, TX: The Psychological Corporation.
47. Wechsler, D. (1997b). Wechsler Adult Intelligence Scale: Administration and scoring manual, 3rd ed. New York: The Psychological Corporation.
48. Wickham, R. (2007). Chemotherapy-induced peripheral neuropathy: A review and implications for oncology nursing practice. Clinical Journal of Oncology Nursing, 11(3), 361-376.
49. Yellen, S. B., Cella, D. F., Webster, K., Blendowski, C., & Kaplan, E. (1997). Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. Journal of Pain and Symptom Management, 13(2), 63-74. (Pubitemid 27147321)
50. Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatricia Scandinavica, 67, 361-370. (Pubitemid 13098606)